Exide Industries Rating: Buy
Total Page:16
File Type:pdf, Size:1020Kb
Auto India I Equities Company Update Change in Estimates Target Reco 30 January 2021 Exide Industries Rating: Buy Target Price: Rs.249 Strong replacement and OEM to drive growth; maintaining a Buy Share Price: Rs.194 Continued expectation of market-share loss in two-wheelers and lower Key data EXID IN / EXID.BO inverter sales would impact Exide’s revenue and earnings this year. 52-week high / low Rs209 / 122 However, we expect the low-base-effect-driven growth in both its OEM Sensex / Nifty 46286 / 13635 and aftermarket businesses in FY22. With this, we maintain our Buy 3-m average volume $12.7m rating, at a higher target price of Rs.249 at 14x FY23e. Market cap Rs164bn / $2254.5m Shares outstanding 850m Continued expectation of decline in market share. The quarter saw strong growth across verticals. Our channel checks suggest that the company has lost Shareholding pattern (%) Dec'20 Sep'20 Jun'20 market share in two-wheeler OEMs and in the replacement market too. Promoters 46. 0 46.0 46.0 However, we expect Exide to recover in four-wheeler OEMs as markets - of which, Pledged --- recover, and in the industrial business in the following quarters. Thus, we Free float 54.0 54.0 54.0 expect revenues to be flat in FY21 and grow 26% in FY22. - Foreign institutions 10.4 9.8 9.1 - Domestic institutions 27.3 23.1 22.9 Margin expansion in FY22. We expect margins of 13.2% in FY21, against - Public 16.4 21.1 22.1 13.3% in 9M FY21. We believe the margin would sustain as we expect strong replacement growth. However, we expect it to expand in FY22 due to a strong Estimates revision (%) FY21e FY221e pick-up in volumes. Revenue 22.0 22.0 EBITDA 22.0 22.0 Introducing FY23e. We expect FY23 revenues to grow 12% y/y, with a PAT 30.5 28.4 comfortable 14.4% margin, against 13% in FY21, and earnings to grow 16% y /y to Rs.13.2bn. Relative price performance 260 Valuation. We expect 19% revenue CAGR over FY21-23, and the margin to 240 expand to 14.4%. Accordingly, we expect earnings of Rs13bn due to 1) the 220 200 sound performance of OEMs, 2) the better product mix and 3) a higher 180 ` 160 aftermarket share, leading to an EPS of Rs.16. We maintain a Buy rating, with 140 a TP of Rs249 (14x FY23e), including Rs.31 a share for Exide Life Insurance. 120 100 Risk: Less-than-estimated growth in FY22. Jul-20 Jan-21 Jan-20 Sep-20 Nov-20 Mar-20 May-20 EXID Sensex Source: Bloomberg Key financials (YE Mar) FY19 FY20 FY21e FY22e FY23e Sales (Rs m) 105,883 98,567 98,567 124,194 139,097 Net profit (Rs m) 8,440 8,255 7,982 11,379 13,223 EPS (Rs) 9.0 10.0 9.4 13.4 15.6 PE (x) 21.5 19.4 20.6 14.5 12.4 EV / EBITDA (x) 11.4 11.9 12.1 8.8 7.6 PBV (x) 2.7 2.6 2.4 2.2 2.0 Vijay Sarthy TS Research Analyst RoE (%) 14.8 13.4 12.2 15.9 16.7 RoCE (%) 13.6 13.8 12.3 15.9 16.7 Dividend yield (%) 1.5 2.5 1.8 2.6 3.0 Akshay Karwa Net debt / equity (x) -0.1 -0.0 -0.1 -0.1 -0.2 Research Associate Source: Company, Anand Rathi Research Anand Rathi Share and Stock Brokers Limited (hereinafter “ARSSBL”) is a full-s ervice brokerage and equities-research f irm and t he views expressed therein are solely of ARSSBL and not of the companies which have been covered in the Rese arch Report. This r eport is intended for the s ole use of the Recipient. Disclosures and analyst certifications are present in the Appendix. AnandRathi Research India Equities 30 January 2021 Exide Industries – Strong replacement and OEM to drive growth; maintaining a Buy Quick Glance – Financials and Valuations Fig 1 – Income statement (Rs m) Fig 2 – Balance sheet (Rs m) Year-end: Mar FY19 FY20 FY21e FY22e FY23e Year-end: Mar FY19 FY20 FY21e FY22e FY23e Net revenues 105,883 98,567 98,567 124,194 139,097 Share capital 850 850 850 850 850 Growth (%) 15.3 -6.9 - 26.0 12.0 Net worth 59,870 62,961 67,994 75,168 83,505 Raw material cost 69,702 62,664 62,393 78,615 87,631 Debt - - - - - Employee costs 6,377 6,664 7,195 8,569 9,598 Minority interest - - - - - Other direct costs 15,691 15,589 15,968 19,498 21,838 DTL / (Assets) 1,751 1,019 1,019 1,019 1,019 EBITDA 14,113 13,650 13,011 17,511 20,030 Capital employed 61,621 63,980 69,012 76,186 84,523 EBITDA margins (%) 13.3 13.8 13.2 14.1 14.4 Net tangible assets 22,660 22,755 23,641 23,147 22,321 - Depreciation 3,135 3,626 3,614 3,994 4,326 Net intangible assets 313 365 313 313 313 Other income 385 639 707 845 972 Goodwill - - - - - Interest expenses 61 94 94 94 94 CWIP (tang. & intang.) 2,549 3,243 1,969 1,969 1,969 Exceptional items 1,083 -217 - - - Investments (strategic) 19,455 20,863 21,648 21,648 21,648 PBT 12,386 10,352 10,010 14,269 16,582 Investments (financial) 2,539 187 4,419 8,651 12,883 Effective tax rate (%) 32 20 20 20 20 Current assets (ex cash) 33,473 33,462 32,939 37,293 43,522 Net Income 8,440 8,255 7,982 11,379 13,223 Cash 736 1,546 2,524 1,607 309 Adjusted income 7,664 8,472 7,982 11,379 13,223 Current liabilities 20,103 18,441 18,441 18,441 18,441 WANS 850 850 850 850 850 Working capital 13,370 15,021 14,498 18,852 25,081 FDEPS (Rs / sh) 9.0 10.0 9.4 13.4 15.6 Capital deployed 61,621 63,980 69,012 76,186 84,523 Fig 3 – Cash-flow statement (Rs m) Fig 4 – Ratio analysis Year-end: Mar FY19 FY20 FY21e FY22e FY23e Year-end: Mar FY19 FY20 FY21e FY22e FY23e PBT 12,386 10,352 10,010 14,269 16,582 P/E (x) 21.5 19.4 20.6 14.5 12.4 + Non-cash items 3,135 3,626 3,614 3,994 4,326 EV / EBITDA (x) 11.4 11.9 12.1 8.8 7.6 Oper. prof. before WC 15,521 13,978 13,624 18,263 20,908 EV / Sales (x) 1.5 1.7 1.6 1.2 1.1 - Incr. / (decr.) in WC 552 1,651 -522 4,354 6,229 P/B (x) 2.7 2.6 2.4 2.2 2.0 Others incl. taxes 3,794 2,097 2,027 2,890 3,359 RoE (%) 14.8 13.4 12.2 15.9 16.7 Operating cash-flow 11,175 10,231 12,119 11,019 11,321 RoCE (%) - after tax 13.6 13.8 12.3 15.9 16.7 - Capex (tang. + intang.) 6,739 4,467 3,174 3,500 3,500 RoIC (%) - after tax 13.8 14.1 12.4 16.4 16.9 Free cash-flow 4,437 5,764 8,945 7,519 7,821 DPS (Rs / sh) 2.9 4.9 3.5 4.9 5.7 Acquisitions - - - - - Dividend yield (%) 1.5 2.5 1.8 2.6 3.0 - Div.(incl. buyback & taxes) 2,459 4,154 2,950 4,205 4,886 Dividend payout (%) - incl. DDT 29.1 50.3 37.0 37.0 37.0 + Equity raised - - - - - Net debt / equity (x) -0.1 -0.0 -0.1 -0.1 -0.2 + Debt raised - - - - - Receivables (days) 35 35 35 35 33 - Fin investments 2,304 -944 5,017 4,232 4,232 Inventory (days) 93 116 116 118 112 - Misc. (CFI + CFF) (191) 1,743 (0) 0 (0) Payables (days) 51 59 59 59 56 Net cash-flow -136 810 978 -918 -1,298 CFO : PAT % 145.8 120.8 151.8 96.8 85.6 Source: Company, Anand Rathi Research Source: Company, Anand Rathi Research Fig 5 – Price movement Fig 6 – Gross-margin and lead-price growth trends (Rs) 40% 9% 350 35% 6% 300 30% 3% 250 25% 0% 20% -3% 200 15% -6% 150 10% -9% 100 5% -12% 50 0% -15% 0 Q1FY19 Q2FY19 Q3FY19 Q4FY19 Q1FY20 Q2FY20 Q3FY20 Q4FY20 Q1FY21 Q2FY21 Q3FY21 Jul-16 Jul-17 Jul-18 Jul-19 Jul-20 Apr-16 Oct-16 Apr-17 Oct-17 Apr-18 Oct-18 Apr-19 Oct-19 Apr-20 Oct-20 Jan-16 Jan-17 Jan-18 Jan-19 Jan-20 Jan-21 Gross Margin Q-o-q lead price change (RHS) Source: Bloomberg Source: Company Anand Rathi Research 2 30 January 2021 Exide Industries – Strong replacement and OEM to drive growth; maintaining a Buy Quarterly financials Fig 7 –Quarterly performance (Rs m) Q3 FY19 Q4 FY19 Q1 FY20 Q2 FY20 Q3 FY20 Q4 FY20 Q1 FY21 Q2 FY21 Q3 FY21 Net sales 24,968 25,987 27,793 26,109 24,115 20,551 15,476 27,534 28,010 Y/Y (%) 9.6 5.7 0.2 (4.0) (3.4) (20.9) -44% 5.5 16.2 Q/Q (%) (8.2) 4.1 6.9 (6.1) (7.6) (14.8) -25% 77.9 1.7 24,968 25,987 27,793 26,109 24,115 20,551 15,476 27,534 28,010 EXPENDITURE (Incr.) / decr.